Bioassays - Boehringer Ingelheim Therapeutics in Ochsenhausen, Germany
preclinical development, in-vitro-testing, therapeutic antibodies, GMP certified testing, FACS, Luminescence, Absorbance, ELISA, Fluorescence, Fluorescence Polarization, development germany, Design of Experiments (DoE), validation, testing studies, GMP guidelines, US-FDA, European authorities, GMP-compliant testing, Europe, US, therapeutic monoclonal antibodies, bispecific antibodies, proteins, peptides, antigens, vaccines, Binding Assay, ADCC (commercial and customized), CDC, center of excellence, highest standards for bioassays, stability testing, cell based bioassays, in-vitro-testing, therapeutical antibodies
338
page-template,page-template-full_width,page-template-full_width-php,page,page-id-338,page-child,parent-pageid-397,ajax_fade,page_not_loaded,,qode-title-hidden,qode_grid_1300,footer_responsive_adv,qode-child-theme-ver-1.0.0,qode-theme-ver-13.6,qode-theme-bridge,disabled_footer_top,wpb-js-composer js-comp-ver-6.6.0,vc_responsive

Bioassays

Cell Based Bioassays

During preclinical development, the in-vitro-testing for mode of action of e.g. therapeutic antibodies by cell-based bioassays is of crucial importance. With our GMP certified testing facility and our well-experienced staff, Boehringer Ingelheim Therapeutics performs custom tailoring of a wide range of cell-based bioassays, using FACS , Luminescence, Absorbance, ELISA or Fluorescence (Time Resolved Fluorescence and Fluorescence Polarization) as read outs. Starting from development or optimization by Design of Experiments (DoE) to method validation and release testing, all studies are performed according to GMP guidelines and our customer’s demands. Boehringer Ingelheim Therapeutics is inspected by the US-FDA on a regular basis, as well as European authorities.
 
At Boehringer Ingelheim Therapeutics numerous types of cell-based-bioassays are established. GMP-compliant testing, required for applications in Europe as well as in the US, are routinely applied. Special focus is put on therapeutic monoclonal or bispecific antibodies, antibody drug conjugates, cytokines, proteins, peptides, antigens or vaccines:
Reporter Gene Assays
Proliferation Assay
Apoptosis Assay
Competitive Binding Assay
Binding Assay
ADCC (commercial and customized)
CDC

Cytotoxicity

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo. Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo. Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo. Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.